Back to Search
Start Over
First-episode psychosis is associated with oxidative stress: Effects of short-term antipsychotic treatment
- Publication Year :
- 2015
- Publisher :
- Wiley, 2015.
-
Abstract
- AimsIn the present study, our aim was to investigate the oxidative-antioxidative systems in unmedicated first-episode psychosis (FEP) patients at the beginning and after short-term treatment. MethodsThis study consisted of 29 patients who experienced an FEP and 25 control subjects. In order to investigate the oxidative status, we determined plasma malondialdehyde (MDA) levels, oxidizability of red blood cells, oxidation and oxidizability of apolipoprotein B-containing lipoproteins (apo B-basal MDA and apo B-MDA). In order to evaluate the antioxidative defense, we measured serum total antioxidative capacity, uric acid, albumin, total bilirubin and vitamin E levels and serum paraoxonase/arylesterase, whole blood glutathione peroxidase (GPx) and red blood cell superoxide dismutase activities before and after 6 weeks of treatment in patients with FEP. ResultsPlasma MDA and apo B-basal MDA levels and red blood cell superoxide dismutase activity were significantly higher and serum arylesterase and whole blood-GPx activities were lower in the FEP group than those of the healthy control group. There were not any significant changes in the oxidative and antioxidative system parameters (except increased vitamin E levels) after treatment. ConclusionsThe results of this study suggest that FEP is accompanied by oxidative stress. However, further studies are needed to clarify the role of oxidative stress in the physiopathologic mechanisms of FEP, so that oxidative and antioxidative system parameters can be used in the management of these patients. In accordance with psychiatric evaluation, for a better management, patients with FEP may require a multidisciplinary approach, including oxidative and antioxidative system parameters.
- Subjects :
- Male
Erythrocytes
Antipsychotic agents
ALB protein, human
Serum albumin
Carboxylesterase
Low-density-lipoprotein
Plasma
Malondialdehyde
Antioxidant defense
Vitamin E
Disease
Arylesterase
Protein blood level
Enzyme activity
Psychiatry
Psychotic disorders
Neuroleptic agent
Malonaldehyde
Drug-naive patients
APOB protein, human
First-episode psychosis
Erythrocyte
Blood
Clinical neurology
Apolipoprotein B-100
Female
Antioxidant
Apolipoprotein B
Human
Vitamin blood level
Adult
Clinical article
Case control study
Case-control studies
Superoxide dismutase
Patient care
Neurosciences & neurology
Pathophysiology
Article
Oxidation
Carboxylic ester hydrolases
Humans
Clinical evaluation
Lipid peroxide
Onset
Oxidative Stress
Acetylcysteine
Bipolar Disorder
Drug effects
Aryldialkylphosphatase
Albumin
Neurosciences
Alpha tocopherol
Bilirubin
Psychosis
Affective disorders
Oxidation-reduction
Young adult
Metabolism
Sschizophrenia
Oxidative stress
Susceptibility
Short course therapy
Schizophrenia
Glutathione peroxidase
Apolipoprotein B100
Oxidation reduction reaction
Uric acid
Controlled study
Enzyme blood level
Subjects
Details
- Language :
- English
- Database :
- OpenAIRE
- Accession number :
- edsair.od......9458..01b01724ac154e21d7f49b87fb575af5